Tang H, Lu Y, Okun MS, Donahoo WT, Ramirez-Zamora A, Wang F, Huang Y, Armstrong M, Svensson M, Virnig BA, DeKosky ST, Bian J, Guo J (2024) Glucagon-like Peptide-1 receptor agonists and risk of Parkinsons Disease in patients with type 2 diabetes: a Population-based Cohort Study
While sustainable weight loss remains a cornerstone of our Metabolic Reset program, the results of our recently published 2025 Results Report reveal an even more profound impact: Calibrates program drives measurable improvements across key metabolic health metrics, significantly reducing disease risk and lowering long-term healthcare costs
design factorial studies and confirm pathway engagement
10.1093/jn/137.6.1539S 134
When combined with proper diet and regular training, GLP-1 can be a valuable addition to your wellness routine